About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
J
Examining Triplet Therapy in MM: Analysis of ELOQUENT-3 and MAIA Trials
By
Joshua Richter
2 Videos
July 20, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:56
Sanofi
Autologous HCT in Older Adults with MM: Eligibility Assessment
Feat.
T. Wildes
Featured Video
06:53
Sanofi
Geographic and Socioeconomic Disparities in HCT Access for MM: Impac…
Feat.
L. Costa
Related Content
AUTOPLAY
ON
12:38
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Defen…
Feat.
S. Usmani
15:54
Paul Richardson
Emerging Strategies in the Management of Relapsed MM
21:38
Rahul Banerjee
CAR-T Therapy in Myeloma: What's Here and What's Coming So…
09:09
Douglas W. Sborov
IMS 2022 Final Analysis of the GRIFFIN Trial: Daratumumab + Lenalido…
06:41
Hamza Hashmi
Idecabtagene Vicleucel vs. Ciltacabtagene Autoleucel: A Sophie'…
33:28
Cleveland Clinic Taussig Cancer Institute
Management of Relapsed/Refractory Multiple Myeloma
Feat.
F. Anwer
21:16
UChicago Medicine
Myeloma 2022: Challenges and Path Forward
Feat.
A. Jakubowiak
34:28
2022 Community Oncology Conference
Treatment Conundrums in Myeloma
Feat.
S. Giralt
24:19
Dana-Farber Cancer Institute
Phase 3 DETERMINATION Trial: RVd ± ASCT & Lenalidomide Maintenan…
Feat.
P. Richardson
Shambavi Richard
Updates in Sequencing Treatment for Early Multiple Myeloma Relapse
30:59
Houston Methodist Hospital
Overview of Advances in Multiple Myeloma
Feat.
S. Ganguly
19:48
Penn Medicine Abramson Cancer Center
New Therapies for Relapsed Myeloma
Feat.
D. Vogl
10:51
Peter Voorhees
IMS 2022 on Updated Results of a Phase 1, First-in-Human Study of AB…
45:43
MedNews Week
Multiple Myeloma in 2022: Developments, Directions, and Disparities
Feat.
J. Mikhael
20:31
Ambuga Badari
Management of Multiple Myeloma in First Relapse
31:36
Nebraska Oncology Society
ASCO 2022 on Moving Toward a Cure in Myeloma: The Role of MRD Testing
Feat.
A. Nooka
12:09
Dana-Farber Cancer Institute
2022 Treatment Landscape and Future Directions of R/R Multiple Myelo…
Feat.
N. Munshi
10:09
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Next Questions for MM in the Coming 5-10 Years
Feat.
T. Martin
08:49
The Ohio State University - Wexner Medical Center
2022 Updates on the Treatment of Early R/R Multiple Myeloma
Feat.
A. Khan
06:56
Sanofi
Autologous HCT in Older Adults with MM: Eligibility Assessment
Feat.
T. Wildes
